For the latest regulatory status, refer to the MHRA medicines search page and the EMA medicines search page
To date, only a limited number of medications (disulfiram, acamprosate, and naltrexone) have been approved for the treatment of AUD by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA)
Medical History: Inform your doctor about: Gastrointestinal conditions : history of gastroparesis, severe gastro-oesophageal reflux disease (GORD), inflammatory bowel disease, or pancreatitis Mental health conditions : depression, anxiety, or history of substance misuse (relevant for tramadol prescribing) Kidney or liver problems : tramadol may need dose adjustments in significant impairment
In experimental models for the induction of tissue damage, 20 mg/kg MTX was a commonly used dose for rats (Reference Moodi, Hosseini and Abedini16Reference Azadnasab, Kalantar and Khorsandi20)